ApconiX Attends British Toxicology Society Congress – “Celebrating 40 years of the BTS”.

British Toxicology Society (BTS) and the UK Environmental Mutagen Society Annual Congress “Celebrating 40 years of the BTS" will be held at Robinson College, University of Cambridge between 15th -17th of April. Professor Ruth Roberts, Dr Richard Knight, Dr Guy Healing and Phumzile Sikakana will all be attending.  Ruth will be presented with an Honorary Fellowship [...]

By |2019-04-14T16:01:01+01:00April 14th, 2019|Toxicology, Events|Comments Off on ApconiX Attends British Toxicology Society Congress – “Celebrating 40 years of the BTS”.

Successful DMDG Symposium at Alderley Park

The DMDG Symposium at Alderley Park was a great success.  Organised by the teams from Sygnature, Alderley Park and ApconiX, over 120 delegates from around the country joined the symposium Dx Toxicology: Strategies for Success in Discovery and Development, focusing on asking the right questions at the right time around Target, Chemistry and Patient. Speakers [...]

By |2019-03-25T20:09:21+01:00March 26th, 2019|Target Safety Assessments, Events|Comments Off on Successful DMDG Symposium at Alderley Park

ApconiX Celebrates Opening Swedish Office

Dr Michael Morton, Professor Ruth Roberts and Dr Richard Knight flew to Sweden to celebrate the opening of ApconiX AB in Gothenburg by sharing coffee and cake (fika) with our fellow tenants in the BioVentureHub. Experienced toxicologists Drs Steffen Ernst and Björn Dahl, who are based at the new Swedish office, joined the three Directors [...]

By |2019-03-13T11:07:12+01:00March 13th, 2019|Events|Comments Off on ApconiX Celebrates Opening Swedish Office

Symposium – Dx Toxicology: Strategies for Success in Discovery and Development

Attrition due to safety/toxicity remains a challenge in drug discovery and development. Strategies to improve success focus on asking the right questions at the right time around Target, Chemistry and Patient with an emphasis on translation of data to the clinic. Dx Toxicology: Strategies for Success in Discovery and Development is taking place on Thursday [...]

By |2019-02-21T10:06:21+01:00February 20th, 2019|Toxicology, Events|Comments Off on Symposium – Dx Toxicology: Strategies for Success in Discovery and Development

ApconiX Welcomes Dr Steffen Ernst

ApconiX is delighted to welcome Dr Steffen Ernst to our team, as the company begins its international expansion with the formation of its Swedish subsidiary, ApconiX AB. Steffen has worked in preclinical and clinical safety for over 20 years with Hoechst-Schering, Boehringer-Ingelheim, AstraZeneca, Pfizer and Ipsen, holding various pre-clinical and clinical positions of ever-increasing responsibility [...]

By |2019-02-07T16:37:23+01:00February 6th, 2019|Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Steffen Ernst

ApconiX Welcomes Steve Snyder

ApconiX is delighted to welcome Steve Snyder to the team.  Steve joins the nonclinical study monitoring team and is based in Florida in the United States. Having worked at Wyeth, Eli Lilly, McNeil Pharmaceutical and Charles River, Steve has a wealth of experience in preclinical toxicology as both an outsourcing customer and provider.  He is [...]

By |2019-02-06T09:53:22+01:00February 6th, 2019|Nonclinical Study Monitoring, Careers|Comments Off on ApconiX Welcomes Steve Snyder

ApconiX Welcomes Dr Bjorn Dahl

ApconiX is delighted to welcome Dr Björn Dahl to the team, who joins our new Swedish office at AstraZeneca’s BioVentureHub in Gothenburg. Björn is a highly respected and experienced toxicologist, having been the co-chair of the European Federation Pharmaceutical Industry Association (EFPIA) Preclinical Development Expert Working Group and served as the EFPIA topic lead in [...]

By |2019-05-08T12:20:38+01:00February 6th, 2019|Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Bjorn Dahl

Professor Ruth Roberts on SOT Ballot

ApconiX is happy to announce that Professor Ruth Roberts is on the SOT ballot for the position of Vice President-Elect.  As Secretary to SOT, Ruth was the first non-US based Council member and now hopes to be the first non-US based President! ‘It’s a great honour to be asked to stand for election to lead [...]

By |2019-02-06T11:28:11+01:00January 9th, 2019|Events|Comments Off on Professor Ruth Roberts on SOT Ballot

Highlight Article for Experimental Biology and Medicine

“Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration”, co-authored by Abigail L Walker, Syed Z Imam and  Ruth A Roberts, has been selected as a highlight article for Experimental Biology and Medicine’s 243:13 issue. As a result of this designation it will be open access for 90 days. Click here to access Abstract The [...]

By |2018-12-06T13:53:13+01:00December 7th, 2018|Publications|Comments Off on Highlight Article for Experimental Biology and Medicine

Choosing the right non-clinical CRO

Non-clinical contract research organisations (CROs) are an integral part of modern drug development. For any novel agent, delivery of GLP toxicity data to support clinical trials is a crucial step that requires a professional organisation with dedicated management, infrastructure and a broad array of technical and scientific skills. In selecting a CRO, the sponsor typically [...]

By |2018-09-12T14:07:14+01:00September 19th, 2018|Toxicology, Press|Comments Off on Choosing the right non-clinical CRO